Replication efficiency and sequence analysis of full-length hepatitis B virus isolates from hepatocellular carcinoma tissues

International Journal of Cancer

Volumn 102, Issue 5, 2002, Pages 487-491

  Lin, Xu ^a   Zhang Mei, Ma ^a   Yao, Xin ^a   Zhang, Yan Ping ^a   Wen, Yu Mei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Replication

Indexed keywords

EPITOPE;

ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CANCER RISK; CHINESE; GENOMICS; GENOTYPE; HELPER CELL; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; STOP CODON; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TYPING;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; DNA, VIRAL; ENHANCER ELEMENTS (GENETICS); GENOME, VIRAL; GENOTYPE; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; VIRUS REPLICATION;

EID: 0037058708     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10733     Document Type: Article

References (21)

1. Yang BH, Tang ZY. Hepatitis B virus and hepatocellular carcinoma clinical and serological aspect. In: Tang ZY, ed. Subclinical Hepatocellular Carcinoma. Springer-Verlag, Berlin, 1985. 212-7.
2. Lin X, Qian GS, Lu PX, Wu L, Wen YM. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma. J Med Virol 2001;64:299-304.
3. Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology 2000;31:1037-44.
4. Gunther S, Li BC, Miska S, Miska S, Kruger DH, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genome permit rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995;69:5437-44.
5. Maniatis T, Fritsch EF, Sambrook KJ. Molecular Cloning: A Laboratory Manual, 1st Ed. Cold Spring, NY: Cold Spring Harbor Laboratory Press, 1982. 382-98.
6. Gerlich WH, Deepen R, Heermann KH, Korone B, Lu XY, Seifer M, Thomssen R. Protective potential of hepatitis B virus antigens other than the S gene protein. Vaccine 1990;8:63-8.
7. Krone B, Gerlich WH, Heermann KH, Lenz A, Lu XY, Seifer M, Thomssen R. Significance of pre-s antigens for hepatitis B vaccine. Prog Hepatitis B Immun 1990;194:21-33.
8. Tai PC, Banik D, Lin GI, Pai S, Lin MH, Yuoh G, Che S, Hsu SH, Chen TC, Kuo TT, Lee CS, Yang CS, Shih C. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J Virol 1997;71:4952-56.
9. Hosono S, Tai PC, Wang W, Ambrose M, Hwang DG, Yuan TT, Peng BH, Yang CS, Lee CS, Shih C. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology 1995;212:151-62.
10. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
11. Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Drame B, London WT. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 1998;7:559-65.
12. Gu JR. Viral hepatitis B and primary hepatic cancer. In: Wen YM, Xu ZY, Melnick JL, eds. Viral Hepatitis in China: Problems and Control Strategies. Basel: Karger, 1992, 56-75.
13. Raimondo G, Burk RD, Lieberman HM, Muschel J, Hadziyannis SJ, Will H, Kew MC, Dusheiko GM, Shafritz DA. Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 1988;166:103-12.
14. Takahashi K. Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: Comparative analysis of 40 full-length isolates. Arch Virol 1998;143:2313-26.
15. + cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000;191:1269-80.
16. Lian Z, Liu J, Pan J, Tufan NLS, Zhu M, Arbuthnot P, Kew M, Clayton MM, Feitelson M. A cellular gene upregulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival. Hepatology 2001;34:146-57.
17. Lara-Pezzi E, Majano PL, Gomez-Gonzalo M, Garcia-Monzon C, Moreno-Otero R, Levrero M, Lopez-Cabrera M. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocyte. Hepatology 1998;28:1013-21.
18. Friedt M, Gerner P, Lausch E, Trubel H, Zabel B, Wirth S. Mutations in the basic core promoter and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 1999;29:1252-8.
19. Santantonio T, Jung MC, Schneider R, Fernholz D, Milella M, Monno L, Pastore G, Pape GR, Will H. Hepatitis B virus genome that can not synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology 1992;188:948-52.
20. Preikschat P, Gunther S, Reinhold S, Will H, Budde K, Neumayer HH, Kruger D, Meisel H. Complex HBV populations with mutations in core promoter, c gene and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002;55:466-77.
21. Wang L, Tang ZY, Qin LX, Wu XF, Sun HC, Xue Q, Ye SL. High-dose and long-term therapy with interferon-alpha inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Hepatology 2000;32:43-8.